NCT04282187 2026-03-16Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative NeoplasmsUniversity of WashingtonPhase 2 Recruiting25 enrolled
NCT03970096 2026-03-12Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)Fred Hutchinson Cancer CenterPhase 2 Recruiting120 enrolled